THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Astellas and Vir Biotechnology enter global collaboration for VIR-5500

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Astellas and Vir Biotechnology entered a global strategic collaboration to co-develop and co-commercialize VIR-5500, a PSMA-targeting dual-masked T-cell engager for prostate cancer.

Current status
Official collaboration
Known availability
Started 2026-02-23; the official source does not state an end date.
Place
International, Global
Source checked
September 13, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.